Project Grants
Apply for a Project Grant to support your blood cancer research. Because the time to beat blood cancer is now.
Introduction
Our Project Grants support world class research proposals that aim to address vital questions in the field of blood cancer in line with our strategic aims and the priorities of people affected by blood cancer.
Our current strategy focuses on bringing forward the day when no one dies of blood cancer or its treatments. We are looking to maximising our research impact by increasing the amount we spend on research and by targeting that spend in the areas where it will have the most effect.
Process and timeline
- Applications open: Thursday 6th November 2025
- Deadline for submission of applications: 3pm on Thursday 5th February 2026
- Applicants notified of outcomes: July 2026
- Applications should be made through our online Grant Management System Grant Tracker. Guidance on using Grant Tracker can be found here.
- Download our Project Grant guidance for applicants (pdf) below for more details.
Grant amount
Grants will typically be awarded for up to three years for a maximum of £300,000.
Remit and eligibility
Project Grants provide support for clearly defined research projects that aim to address key questions in the field of blood cancers and must address at least one of the three priorities outlined in our new research strategy:
Applicants should clearly outline the potential impact for people affected by blood cancer.
Project Grants are not for:
- Supplementing or making up shortfalls in funding for ongoing research and staff funded by other awards.
- Bridging support between grants.
- Biobank funding or other infrastructure costs.
The scheme's impact
Project Grants have formed the backbone of our funding portfolio over the last 65 years. These grants support world class research that addresses key questions that could help to move us closer to reaching our goal of a world where no one dies as a result of blood cancer or the side effects of its treatment.
-
11 Grants awarded
-
£3.2 million Total invested
-
23% Applicant success rate
Our research
Our £500 million investment in research since 1960 has helped transform treatments and taken us to the point where beating blood cancer is now in sight. Our researchers are working to finish the job.
More About This